Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinaciguat in Acute Decompensated Heart Failure
NCT01065077Phase 2Terminated
- Sponsor
- Bayer
- Start
- Mar 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 2 trial of cinaciguat in heart failure (HF), sponsored by Bayer. Started Mar 2010; status: terminated.
02
Drugs
cinaciguat
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01065077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01065077.